wpesig-user-profile

Tirzepatide Consent

EnnuLife Patient Docs
E-signature Logo
1 of 1 page

Tirzepatide Consent

Informed Consent for the Use of Compounded Tirzepatide

(Telehealth or Brick-and-Mortar)

Date: {{current_date}}

Patient Information

  • **Patient Name: {{patient_first_name}} {{patient_last_name}} {{patient_first_name}} {{patient_last_name}}** {{patient_input}}
  • **Date of Birth: {{patient_birthdate}}** {{patient_input}}

Purpose of This Form

The purpose of this form is to inform you of the potential benefits and risks associated with the use of compounded tirzepatide and to obtain your informed consent to proceed with this treatment.

About Compounded Tirzepatide

This informed consent form is for the use of compounded tirzepatide, a medication that is custom-made for individual patients. Compounded medications are not approved by the U.S. Food and Drug Administration (FDA) and may not have undergone the same level of testing and review as FDA-approved medications.

Tirzepatide is a peptide-based medication that is used to treat obesity and type 2 diabetes. Compounded tirzepatide is a customized form of this medication that is made by a compounding pharmacy to meet the specific needs of an individual patient.

Benefits

The use of compounded tirzepatide may help promote weight loss, improve blood sugar control, and reduce the risk of complications associated with type 2 diabetes.

Risks and Side Effects

Like any medication, compounded tirzepatide may cause side effects, including nausea, vomiting, diarrhea, and headache. In rare cases, more serious side effects such as pancreatitis, gallstones, kidney damage and stomach paralysis may occur.

Important Safety Information

Compounded medications are not approved by the FDA and may not have undergone the same level of testing and review as FDA-approved medications. The safety and efficacy of compounded tirzepatide have not been fully established, and there may be unknown risks associated with its use.

Patient Consent

By signing this form, I acknowledge that I have been fully informed of the potential benefits and risks associated with the use of compounded tirzepatide. I understand that this medication is not FDA-approved and that there may be unknown risks associated with its use. I give my informed consent to proceed with this treatment.

Signatures

Patient Signature: {{patient_input}} Date: {{patient_input}}

Provider Signature: {{patient_input}} Date: {{patient_input}}


Medical Services provided by Primary Medical of KY, P.S.C., Elite Health Services, P.A., CO., Primary Medical of IN, P.C.

Form Complete

Waiting for signature

Ted Ennenbach

ted@ennu.co

Waiting for signature

Ted Ennenbach

ted@ennu.co

Waiting for signature

Ted Ennenbach

ted@ennu.co

Waiting for signature

Ted Ennenbach

ted@ennu.co

Waiting for signature

Lynn Scott

lscott@ennu.co

Waiting for signature

Lynn Scott

lscott@ennu.co

Waiting for signature

Lynn Scott

lscott@ennu.co

Waiting for signature

Lynn Scott

lscott@ennu.co

Signed by: EnnuLife Patient Docs

Signed on: March 9, 2026

Signed by: EnnuLife Patient Docs

Signed on: March 9, 2026

Signed by: EnnuLife Patient Docs

Signed on: March 9, 2026

Signed by: EnnuLife Patient Docs

Signed on: March 9, 2026


Signature Certificate
Tirzepatide Consent
Lock icon Unique Document ID: a8fcfcce33af10b241dcfcdb298f20ddb80191bf
EnnuLife Patient Docs
Party ID: 912778d3-c6da-470f-8c3c-b93a78d14947
IP Address: 24.238.5.27
Digital Signature:
Signer signature
Multi-Factor
Digital Fingerprint Checksum
b754e7a5c814cc0081eda4bda8fe525c
Digital fingerprint checksum barcode
Lynn Scott
Party ID: 9b317c7c-cb4c-47e2-b751-d35f95204d2d
Awaiting signature
Ted Ennenbach
Party ID: 53ef3992-70b1-4f77-87d7-c48bb41977d1
Awaiting signature
Timestamp Audit
UTCDocument
Uploaded by Luis Escobar - lescobar@ennulife.com
IP:
2026-03-09 12:22:31 UTCDocument viewed
IP:
2026-03-09 12:22:43 UTCDocument signed by EnnuLife Patient Docs - docs-admin-ennulife@ennulife.com
IP: 24.238.5.27
Well done you did it! d
Image link
Image link
General Popup with Launcher

Creating popups has never been easier thanks to pixfort's next-generation popup builder.

Do you have presale questions?

Contact our team if you have any question

Our usual reply time: 1 Business day

Follow us on

Image link
Image link
General Popup with Launcher

Creating popups has never been easier thanks to pixfort's next-generation popup builder.

Do you have presale questions?

Contact our team if you have any question

Our usual reply time: 1 Business day

Follow us on

Image link
Hey there

Search for a specific article on our website

Get started

Check these useful guides to get started

Still need Help?

Send us a support message

Our usual reply time: 1 Business day
Contact us

Our team will reply as soon as possible.

[contact-form-7 id=”aa06684″ title=”Simple Contact Form”]

Our usual reply time: 1 Business day